Glycolytic activity in human immune cells: inter-individual variation and functional implications during health and diabetes-Immunometabolism-CSCIED科技核心评价数据库-手机版

Glycolytic activity in human immune cells: inter-individual variation and functional implications during health and diabetes

Glycolytic activity in human immune cells: inter-individual variation and functional implications during health and diabetes

ES评分 0 浏览量：1024 下载量：0

全文阅读下载引用收藏

DOI	10.1097/IN9.0000000000000008
刊名	Immunometabolism IJ
年，卷(期)	2022, 4(4)
作者	Vrieling, Frank; van Dierendonck, Xanthe A. M. H.; Jaeger, Martin; Janssen, Anna W. M.; Hijmans, Anneke; Netea, Mihai G.; Tack, Cees J.; Stienstra, Rinke,
作者单位	[Vrieling, Frank; van Dierendonck, Xanthe A. M. H.; Stienstra, Rinke] Wageningen Univ, Div Human Nutr & Hlth, Wageningen, Netherlands; [van Dierendonck, Xanthe A. M. H.; Jaeger, Martin; Janssen, Anna W. M.; Hijmans, Anneke; Netea, Mihai G.; Tack, Cees J.;
摘要	An increase in glucose uptake driving aerobic glycolysis is a robust hallmark of immune cell activation. The glycolytic response supports functional alterations of the innate immune cells including the production and release of cytokines. Large inter-individual differences in the magnitude of this cytokine response are known to exist. In addition, the presence of disease is known to impact on immune cell function. Whether variation in metabolic responses of immune cells exist between individuals during health or disease is currently unknown. Here, we explore inter-individual differences in the glycolytic rate of immune cells using lactate production as readout upon activation using a variety of different stimuli. Glycolytic responses are subsequently associated to functional immune cell responses in healthy humans. In addition, we determined the glycolytic rate of immune cells and its association with immune function using patients diagnosed with diabetes mellitus. Based on the relative increase in lactate production after activation, distinct clusters of low, intermediate, and high responders could be identified, illustrating the existence of variation in glycolytic responses in healthy subjects. Interestingly, the production of cytokines mirrored these high-, intermediate-, and low-lactate patterns after pathogenic stimulation. In patients with diabetes mellitus, a reduced correlation was found between lactate and cytokine production, specifically for IL-6. Furthermore, based on the relative increase in lactate production, variability in the glycolytic response was reduced compared to healthy subjects. In conclusion, our results show a specific association between the glycolytic rate and function in human immune cells after stimulation with different pathogens. In addition to demonstrating the existence of glycolytic variability and specificity depending on the type of stimulus, the association between glycolysis and function in innate immune cells is altered during the presence of diabetes.
Abstract	An increase in glucose uptake driving aerobic glycolysis is a robust hallmark of immune cell activation. The glycolytic response supports functional alterations of the innate immune cells including the production and release of cytokines. Large inter-individual differences in the magnitude of this cytokine response are known to exist. In addition, the presence of disease is known to impact on immune cell function. Whether variation in metabolic responses of immune cells exist between individuals during health or disease is currently unknown. Here, we explore inter-individual differences in the glycolytic rate of immune cells using lactate production as readout upon activation using a variety of different stimuli. Glycolytic responses are subsequently associated to functional immune cell responses in healthy humans. In addition, we determined the glycolytic rate of immune cells and its association with immune function using patients diagnosed with diabetes mellitus. Based on the relative increase in lactate production after activation, distinct clusters of low, intermediate, and high responders could be identified, illustrating the existence of variation in glycolytic responses in healthy subjects. Interestingly, the production of cytokines mirrored these high-, intermediate-, and low-lactate patterns after pathogenic stimulation. In patients with diabetes mellitus, a reduced correlation was found between lactate and cytokine production, specifically for IL-6. Furthermore, based on the relative increase in lactate production, variability in the glycolytic response was reduced compared to healthy subjects. In conclusion, our results show a specific association between the glycolytic rate and function in human immune cells after stimulation with different pathogens. In addition to demonstrating the existence of glycolytic variability and specificity depending on the type of stimulus, the association between glycolysis and function in innate immune cells is altered during the presence of diabetes.
关键词	glycolysis; human immune cell function; lactate
KeyWord	glycolysis; human immune cell function; lactate
基金项目
页码	1-11

参考文献
相关文献

[1]. Buck MD, Sowell RT, Kaech SM, et al. Metabolic instruction of immunity. Cell. 2017;169(4):570–86. doi: 10.1016/j.cell.2017.04.004.

[2]. O’Neill LAJ, Kishton RJ, Rathmell J. A guide to immunometabolism for immunologists. Nat Rev Immunol. 2016;16(9):553–65. doi: 10.1038/nri.2016.70.

[3]. Makowski L, Chaib M, Rathmell JC. Immunometabolism: from basic mechanisms to translation. Immunol Rev. 2020;295(1):5–14. doi: 10.1111/imr.12858.

[4]. Lachmandas E, Boutens L, Ratter JM, et al. Microbial stimulation of different Toll-like receptor signalling pathways induces diverse metabolic programmes in human monocytes. Nat Microbiol. 2016;2:16246. doi: 10.1038/nmicrobiol.2016.246.

[5]. Krawczyk CM, Holowka T, Sun J, et al. Toll-like receptor-induced changes in glycolytic metabolism regulate dendritic cell activation. Blood. 2010;115(23):4742–9. doi: 10.1182/blood-2009-10-249540.

[6]. Galván-Peña S, Carroll RG, Newman C, et al. Malonylation of GAPDH is an inflammatory signal in macrophages. Nat Commun. 2019;10(1):338. doi: 10.1038/s41467-018-08187-6.

[7]. Rodríguez-Prados J-C, Través PG, Cuenca J, et al. Substrate fate in activated macrophages: a comparison between innate, classic, and alternative activation. J Immunol. 2010;185(1):605–14. doi: 10.4049/jimmunol.0901698.

[8]. Jha AK, Huang SCC, Sergushichev A, et al. Network integration of parallel metabolic and transcriptional data reveals metabolic modules that regulate macrophage polarization. Immunity. 2015;42(3):419–30. doi: 10.1016/j.immuni.2015.02.005.

[9]. De Rosa V, Galgani M, Porcellini A, et al. Glycolysis controls the induction of human regulatory T cells by modulating the expression of FOXP3 exon 2 splicing variants. Nat Immunol. 2015;16(11):1174–84. doi: 10.1038/ni.3269.

[10]. Chang CH, Curtis JD, Maggi LB, et al. XPosttranscriptional control of T cell effector function by aerobic glycolysis. Cell. 2013;153(6):1239–51. doi: 10.1016/j.cell.2013.05.016.

[11]. Michalek RD, Gerriets VA, Jacobs SR, et al. Cutting edge: distinct glycolytic and lipid oxidative metabolic programs are essential for effector and regulatory CD4+ T cell subsets. J Immunol. 2011;186(6):3299–303. doi: 10.4049/jimmunol.1003613.

[12]. Wang R, Dillon CP, Shi LZ, et al. The transcription factor Myc controls metabolic reprogramming upon T lymphocyte activation. Immunity. 2011;35(6):871–82. doi: 10.1016/j.immuni.2011.09.021.

[13]. Mills EL, Kelly B, Logan A, et al. Succinate dehydrogenase supports metabolic repurposing of mitochondria to drive inflammatory macrophages. Cell. 2016;167(2):457–70.e13. doi: 10.1016/j.cell.2016.08.064.

[14]. Pfeiffer T, Schuster S, Bonhoeffer S. Cooperation and competition in the evolution of ATP-producing pathways. Science. 2001;292(5516):504–7. doi: 10.1126/science.1058079.

[15]. Harber KJ, de Goede KE, Verberk SGS, et al. Succinate is an inflammation-induced immunoregulatory metabolite in macrophages. Metabolites. 2020;10(9):372. doi: 10.3390/metabo10090372.

[16]. Swain A, Bambouskova M, Kim H, et al. Comparative evaluation of itaconate and its derivatives reveals divergent inflammasome and type I interferon regulation in macrophages. Nat Metab. 2020;2(7):594–602. doi: 10.1038/s42255-020-0210-0.

[17]. Izquierdo E, Cuevas VD, Fernández-Arroyo SR, et al. Reshaping of human macrophage polarization through modulation of glucose catabolic pathways. J Immunol. 2015;195(5):2442–2451.

[18]. Tannahill G, Curtis A, Adamik J, et al. Succinate is a danger signal that induces IL-1β via HIF-1α. Nature. 2013;496(7444):238–42.

[19]. Moon JS, Hisata S, Park MA, et al. MTORC1-induced HK1-dependent glycolysis regulates NLRP3 inflammasome activation. Cell Rep. 2015;12(1):102–15. doi: 10.1016/j.celrep.2015.05.046.

[20]. Suzuki H, Hisamatsu T, Chiba S, et al. Glycolytic pathway affects differentiation of human monocytes to regulatory macrophages. Immunol Lett. 2016;176:18–27. doi: 10.1016/j.imlet.2016.05.009.

[21]. Kovarik JJ, Kernbauer E, Hölzl MA, et al. Fasting metabolism modulates the interleukin-12/interleukin-10 cytokine axis. PLoS One. 2017;12(7):e0180900. doi: 10.1371/journal.pone.0180900.

[22]. Aguirre-Gamboa R, Joosten I, Urbano PCM, et al. Differential effects of environmental and genetic factors on T and B cell immune traits. Cell Rep. 2016;17(9):2474–87. doi: 10.1016/j.celrep.2016.10.053.

[23]. Schirmer M, Smeekens SP, Vlamakis H, et al. Linking the human gut microbiome to inflammatory cytokine production capacity. Cell. 2016;167(4):1125–36.e8. doi: 10.1016/j.cell.2016.10.020.

[24]. Li Y, Oosting M, Deelen P, et al. Inter-individual variability and genetic influences on cytokine responses to bacteria and fungi. Nat Med. 2016;22(8):952–60. doi: 10.1038/nm.4139.

[25]. Li Y, Oosting M, Smeekens SP, et al. A functional genomics approach to understand variation in cytokine production in humans. Cell. 2016;167(4):1099–110.e14. doi: 10.1016/j.cell.2016.10.017.

[26]. Bakker OB, Aguirre-Gamboa R, Sanna S, et al. Integration of multi-omics data and deep phenotyping enables prediction of cytokine responses. Nat Immunol. 2018;19(7):776–86. doi: 10.1038/s41590-018-0121-3.

[27]. ter Horst R, Jaeger M, Smeekens SP, et al. Host and environmental factors influencing individual human cytokine responses. Cell. 2016;167(4):1111–24.e13. doi: 10.1016/j.cell.2016.10.018.

[28]. Hotamisligil GS. Inflammation, metaflammation and immunometabolic disorders. Nature. 2017;542(7640):177–85. doi: 10.1038/nature21363.

[29]. Carey IM, Critchley JA, Dewilde S, et al. Risk of infection in type 1 and type 2 diabetes compared with the general population: a matched cohort study. Diabetes Care. 2018;41(3):513–21. doi: 10.2337/dc17-2131.

[30]. Critchley JA, Carey IM, Harris T, et al. Glycemic control and risk of infections among people with type 1 or type 2 diabetes in a large primary care cohort study. Diabetes Care. 2018;41(10):2127–35. doi: 10.2337/dc18-0287.

[31]. Nathan DM, Bebu I, Braffett BH, et al. Risk factors for cardiovascular disease in type 1 diabetes. Diabetes. 2016;65(5):1370–79.

[32]. Laakso M. Cardiovascular disease in type 2 diabetes from population to man to mechanisms: the Kelly West award lecture 2008. Diabetes Care. 2010;33(2):442–9. doi: 10.2337/dc09-0749.

[33]. Domínguez-Andrés J, Arts RJW, ter Horst R, et al. Rewiring monocyte glucose metabolism via C-type lectin signaling protects against disseminated candidiasis. PLoS Pathog. 2017;13(9):e1006632. doi: 10.1371/journal.ppat.1006632.

[34]. Netea MG, Joosten LAB, Li Y, et al. Understanding human immune function using the resources from the Human Functional Genomics Project. Nat Med. 2016;22(8):831–3. doi: 10.1038/nm.4140.

[35]. Teslaa T, Teitell MA. Techniques to monitor glycolysis. Methods Enzymol. 2014;542:91–114. doi: 10.1016/B978-0-12-416618-9.00005-4.

[36]. Bates D, Mächler M, Bolker BM, et al. Fitting linear mixed-effects models using lme4. J Stat Softw. 2015;67(1):1–48.

[37]. Kuznetsova A, Brockhoff PB, Christensen RHB. lmerTest package: tests in linear mixed effects models. J Stat Softw. 2017;82(13):1–26.

[38]. Clogg CC, Petkova E, Haritou A. Statistical methods for comparing regression coefficients between models. Am J Sociol. 1995;100(5):1261–93.

[39]. factoextra: Extract and Visualize the Results of Multivariate Data Analyses. version 1.0.7. Comprehensive R Archive Network (CRAN); 2020. Accessed August 29, 2022. Available from: https://cran.r-project.org/web/packages/factoextra/readme/README.html

[40]. ggplot2 Elegant Graphics for Data Analysis. version 3. Springer-Verlag New York2009. Accessed August 29, 2022. Available from: https://link.springer.com/book/10.1007/978-0-387-98141-3Cited Here
[41]. cowplot: Streamlined Plot Theme and Plot Annotations for “ggplot2”. version 1.1.1. Comprehensive R Archive Network (CRAN); 2020. Accessed August 29, 2022. Available from: https://wilkelab.org/cowplot/

[42]. Palsson-Mcdermott EM, Curtis AM, Goel G, et al. Pyruvate kinase M2 regulates HIF-1α activity and IL-1β induction and is a critical determinant of the Warburg effect in LPS-activated macrophages. Cell Metab. 2015;21(1):65–80. doi: 10.1016/j.cmet.2014.12.005.

[43]. Thiem K, van Dierendonck XAMH, Janssen AWM, et al. A high glycemic burden relates to functional and metabolic alterations of human monocytes in patients with type 1 diabetes. Diabetes. 2020;69(12):db200568.

[44]. Chiba S, Hisamatsu T, Suzuki H, et al. Glycolysis regulates LPS-induced cytokine production in M2 polarized human macrophages. Immunol Lett. 2017;183:17–23. doi: 10.1016/j.imlet.2017.01.012.

[45]. Jiang H, Wei H, Wang H, et al. Zeb1-induced metabolic reprogramming of glycolysis is essential for macrophage polarization in breast cancer. Cell Death Dis. 2022;13(3):206. doi: 10.1038/s41419-022-04632-z.

[46]. Zhang G, Zhao X, Liu W. NEDD4L inhibits glycolysis and proliferation of cancer cells in oral squamous cell carcinoma by inducing ENO1 ubiquitination and degradation. Cancer Biol Ther. 2022;23(1):243–53. doi: 10.1080/15384047.2022.2054244.

[47]. Chen Y, Liu L, Xia L, et al. TRPM7 silencing modulates glucose metabolic reprogramming to inhibit the growth of ovarian cancer by enhancing AMPK activation to promote HIF-1α degradation. J Exp Clin Cancer Res. 2022;41(1):44. doi: 10.1186/s13046-022-02252-1.

[48]. Dinarello CA. Biologic basis for interleukin-1 in disease. Blood. 1996;87(6):2095–147.

[49]. Zhang D, Tang Z, Huang H, et al. Metabolic regulation of gene expression by histone lactylation. Nature. 2019;574(7779):575–80. doi: 10.1038/s41586-019-1678-1.

[50]. Haas R, Smith J, Rocher-Ros V, et al. Lactate regulates metabolic and pro-inflammatory circuits in control of T Cell migration and effector functions. Marrack P, editor. PLoS Biol. 2015;13(7):e1002202. doi: 10.1371/journal.pbio.1002202.

[51]. Dietl K, Renner K, Dettmer K, et al. Lactic acid and acidification inhibit TNF secretion and glycolysis of human monocytes. J Immunol. 2010;184(3):1200–9. doi: 10.4049/jimmunol.0902584.

[52]. Ratter JM, Rooijackers HMM, Hooiveld GJ, et al. In vitro and in vivo effects of lactate on metabolism and cytokine production of human primary PBMCs and monocytes. Front Immunol. 2018;9:2564. doi: 10.3389/fimmu.2018.02564.

[53]. Kawasaki T, Kawai T. Toll-like receptor signaling pathways. Front Immunol. 2014;5(SEP):461. doi: 10.3389/fimmu.2014.00461.

[54]. Jin MS, Kim SE, Heo JY, et al. Crystal structure of the TLR1-TLR2 heterodimer induced by binding of a tri-acylated lipopeptide. Cell. 2007;130(6):1071–82. doi: 10.1016/j.cell.2007.09.008.

[55]. Jin MS, Lee JO. Structures of the toll-like receptor family and its ligand complexes. Immunity. 2008;29(2):182–91. doi: 10.1016/j.immuni.2008.07.007.

[56]. Fournier B, Philpott DJ. Recognition of Staphylococcus aureus by the innate immune system. Clin Microbiol Rev. 2005;18(3):521–40. doi: 10.1128/CMR.18.3.521-540.2005.

[57]. Beutler B. Tlr4: central component of the sole mammalian LPS sensor. Curr Opin Immunol. 2000;12(1):20–6. doi: 10.1016/s0952-7915(99)00046-1.

[58]. Christ A, Günther P, Lauterbach MAR, et al. Western diet triggers NLRP3-dependent innate immune reprogramming. Cell. 2018;172(1-2):162–75.e14. doi: 10.1016/j.cell.2017.12.013.

[59]. Netea MG, Domínguez-Andrés J, Barreiro LB, et al. Defining trained immunity and its role in health and disease. Nat Rev Immunol. 2020;20(6):375–88. doi: 10.1038/s41577-020-0285-6.

[60]. Domínguez-Andrés J, Joosten LA, Netea MG. Induction of innate immune memory: the role of cellular metabolism. Curr Opin Immunol. 2019;56:10–6. doi: 10.1016/j.coi.2018.09.001.

[61]. Cheng SC, Quintin J, Cramer RA, et al. MTOR- and HIF-1α-mediated aerobic glycolysis as metabolic basis for trained immunity. Science. 2014;345(6204):1250684. doi: 10.1126/science.1250684.

[62]. Phan AT, Goldrath AW, Glass CK. Metabolic and epigenetic coordination of T cell and macrophage immunity. Immunity. 2017;46(5):714–29. doi: 10.1016/j.immuni.2017.04.016.

[63]. Fanucchi S, Domínguez-Andrés J, Joosten LAB, et al. The intersection of epigenetics and metabolism in trained immunity. Immunity. 2021;54(1):32–43. doi: 10.1016/j.immuni.2020.10.011.

[64]. Wellen KE, Hatzivassiliou G, Sachdeva UM, et al. ATP-citrate lyase links cellular metabolism to histone acetylation. Science. 2009;324(5930):1076–80. doi: 10.1126/science.1164097.

[65]. Harcourt BE, Penfold SA, Forbes JM. Coming full circle in diabetes mellitus: from complications to initiation. Nat Rev Endocrinol. 2013;9(2):113–23. doi: 10.1038/nrendo.2012.236.

[66]. Caputa G, Castoldi A, Pearce EJ. Metabolic adaptations of tissue-resident immune cells. Nat Immunol. 2019;20(7):793–801. doi: 10.1038/s41590-019-0407-0.

[67]. Norata GD, Caligiuri G, Chavakis T, et al. The cellular and molecular basis of translational immunometabolism. Immunity. 2015;43(3):421–34. doi: 10.1016/j.immuni.2015.08.023.

[68]. Rodrigues CF, Rodrigues ME, Henriques M. Candida sp. infections in patients with diabetes mellitus. J Clin Med. 2019;8(1):76.

引用本文

Vrieling, Frank; van Dierendonck, Xanthe A. M. H.; Jaeger, Martin; Janssen, Anna W. M.; Hijmans, Anneke; Netea, Mihai G.; Tack, Cees J.; Stienstra, Rinke. Glycolytic activity in human immune cells: inter-individual variation and functional implications during health and diabetes [J]. Immunometabolism. 2022; 4; (4). 1 - 11.

文献评论

相关学者

相关机构